More articles from 5.1 Airway Pharmacology and Treatment

MiRNA-183 cluster in response to asthma treatment
Sandra Dragicevic, Vanja Radulovic, Natasa Anastasov, Michael Atkinson, Dragica Radojkovic, Aleksandra Divac Rankov

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4110; DOI: 10.1183/13993003.congress-2016.PA4110
Effectiveness of glycopyrronium bromide in the treatment of small airways dysfunction
Albino Petrone, Filippo Fimognari, Michela Quartieri, Giacomo Bruni

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4080; DOI: 10.1183/13993003.congress-2016.PA4080
Clinical characteristics and outcomes of elderly patients with COPD: TIOSPIR® post-hoc analysis
Daniel Dusser, Peter M.A. Calverley, Robert A. Wise, Achim Mueller, Norbert Metzdorf, Antonio Anzueto

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4083; DOI: 10.1183/13993003.congress-2016.PA4083
Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study
Eirini Mitsiki, Mina Gaga, Niki Georgatou-Papageorgiou, Paraskevi Katsaounou, Epameinondas Kosmas, Nikolaos Koulouris, Elena Panitti, Nikolaos Siafakas, Paschalis Steiropoulos, Michail Toumpis, Nikolaos Tzanakis, Theodoros Vassilakopoulos

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4055; DOI: 10.1183/13993003.congress-2016.PA4055
Effect of tiotropium bromide on IFN-γ level: Results from 180-days study in moderate COPD patients with viral-induced exacerbations in anamnesis
Mariana Kulynych-Miskiv, Mykola Ostrovskyy, Iryna Savelikhina, Oleksandr Varunkiv, Kseniia Ostrovska

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4099; DOI: 10.1183/13993003.congress-2016.PA4099
The effect of aclidinium bromide 400 µg on sleep quality in COPD: A pilot study
Helgo Magnussen, Michael Arzt, Stefan Andreas, Tanja Plate, Anna Ribera, Beatriz Seoane, Henrik Watz, Anne-Marie Kirsten

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4051; DOI: 10.1183/13993003.congress-2016.PA4051
Efficacy and safety of extrafine glycopyrronium bromide pMDI (CHF 5259) in COPD patients
Elzbieta Hajol, Annalisa Piccinno, Isabelle Viaud, Isabella Montagna, Alessandro Guasconi, Stefano Vezzoli, Mario Scuri, Mike Polkey

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4065; DOI: 10.1183/13993003.congress-2016.PA4065
Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials
John R. Hurst, Samy Suissa, Klaus F. Rabe, Giovanni Bader, Gerrit Zijlstra, Marcela Gavornikova, Francesco Patalano, Robert Fogel, Konstantinos Kostikas

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4062; DOI: 10.1183/13993003.congress-2016.PA4062
Clinical evaluation of fluticasone/formoterol twice daily delivered via a single dose dry powder inhaler in patients with persistent asthma
Pradyut Waghray, Mahip Saluja, Mayank Agarwal, Abhijit Vaidya, Jaideep Gogtay, Ashish Kumar Deb, Sneha Limaye, Ashish Goyal, Aloke Gopal Ghoshal, Sudhir Bhatnagar, Akash Balki, George Dsouza, Manish Kumar Jain, Sharad Tikkiwal, Sujeet Rajan, Raja Dhar

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4114; DOI: 10.1183/13993003.congress-2016.PA4114
SQ HDM SLIT-tablet is effective in patients not well-controlled in GINA treatment steps 2-4
Johann Christian Virchow, Victoria Cardona, Hanne Villesen, Christian Ljørring, Bente Riis, Frederic de Blay

European Respiratory Journal Sep 2016, 48 (suppl 60) PA4108; DOI: 10.1183/13993003.congress-2016.PA4108

Main menu

User menu

Search

More articles from 5.1 Airway Pharmacology and Treatment

Pages

Contact us